Your session is about to expire
← Back to Search
Nerve Blocks for Hip Osteoarthritis (PENG Trial)
N/A
Waitlist Available
Led By Ronald Delanois, MD
Research Sponsored by LifeBridge Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up surgery to 1 month post surgery
Awards & highlights
PENG Trial Summary
This trial found that the pericapsular nerve block is more effective than the fascia iliaca nerve block for managing postoperative pain after total hip arthroplasty.
Eligible Conditions
- Hip Osteoarthritis
- Hip Arthritis
PENG Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ surgery to 1 month post surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~surgery to 1 month post surgery
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Visual Analog Pain Scale (VAS) Score
Postoperative Opioid Consumption in mg
Secondary outcome measures
12 Item Short Form Health Survey Version 2
Distance upon first ambulation
Harris Hip Score
+3 morePENG Trial Design
2Treatment groups
Active Control
Group I: Fascia Iliaca Nerve Block GroupActive Control1 Intervention
Fascia Iliaca Nerve Block targets the space between the iliacus muscle and the fascia that overlies it (fascia iliaca), within which the femoral nerve and lateral femoral cutaneous nerve (LFCN) course.
Group II: Pericapsular Nerve Block GroupActive Control1 Intervention
Pericapsular Nerve Block targets the anterior hip capsule by blocking the articular branches of the femoral nerve and accessory obturator nerve.
Find a Location
Who is running the clinical trial?
LifeBridge HealthLead Sponsor
28 Previous Clinical Trials
4,290 Total Patients Enrolled
Rubin Institute for Advanced OrthopedicsUNKNOWN
1 Previous Clinical Trials
100 Total Patients Enrolled
Ronald Delanois, MDPrincipal InvestigatorLifeBridge Health
2 Previous Clinical Trials
830 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- During the surgery, the patient needs to be fully asleep under general anesthesia.You are eligible if you need one of the two types of nerve blocks.You have been diagnosed with a condition called ankylosing spondylitis.You are currently receiving treatment with another experimental drug or any other therapy for pain.You currently have or have had a diagnosis of ongoing pain for a long time.You have allergies to any of the medications used in either of the two groups.
Research Study Groups:
This trial has the following groups:- Group 1: Fascia Iliaca Nerve Block Group
- Group 2: Pericapsular Nerve Block Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger